Literature DB >> 11248333

New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophilia.

M C Cox1, P Panetta, A Venditti, E Abruzzese, G Del Poeta, M Cantonetti, S Amadori.   

Abstract

Idiopathic myelofibrosis (IM), is a chronic myeloproliferative disorder (MPD) characterised by marrow fibrosis, extramedullary haematopoiesis and a leuco-erythroblastic picture of the peripheral blood. Cytogenetic data of IM is scarce: no specific karyotypic anomalies have been yet described. Trisomy 1q, del(13q), del(20q) and trisomy 8, appear in two-thirds of the cases with chromosome aberrations. We report on a 41-year-old patient diagnosed with IM associated with eosinophilia, bearing a novel translocation t(6;10)(q27;q11) as the sole chromosome anomaly. The patient, progressed to AML-M5a within 18 months from diagnosis. Recently new specific chromosomal translocations have been described in chronic MPD. These findings have allowed the classification of new syndromes with defined molecular abnormalities. The case we describe, because of the peculiar clinical features and the association with a previously unreported chromosomal translocation, might be a noteworthy addition.

Entities:  

Mesh:

Year:  2001        PMID: 11248333     DOI: 10.1016/s0145-2126(00)00136-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Somatically acquired mutations in primary myelofibrosis: A case report and meta-analysis.

Authors:  Yongming Xia; Qingxiao Hong; Zhibin Gao; Shijun Wang; Shiwei Duan
Journal:  Exp Ther Med       Date:  2021-01-07       Impact factor: 2.447

2.  Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies.

Authors:  Daniela Bossi; Francesca Carlomagno; Isabella Pallavicini; Giancarlo Pruneri; Maurizio Trubia; Paola Rafaniello Raviele; Alessandra Marinelli; Suresh Anaganti; Maria Christina Cox; Giuseppe Viale; Massimo Santoro; Pier Paolo Di Fiore; Saverio Minucci
Journal:  Mol Oncol       Date:  2013-11-19       Impact factor: 6.603

3.  Complex hypereosinophilia arising from post-polycythemia vera myelofibrosis: A case of imatinib-responsiveness.

Authors:  Ryan D Gentzler; Alex C Minella; Brady L Stein
Journal:  Leuk Res Rep       Date:  2012-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.